Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma

被引：8
|
作者：
Carbone, Antonino [1 ,5 ]
Gloghini, Annunziata [2 ]
Carlo-Stella, Carmelo [3 ,4 ]
机构：
[1] IRCCS, Ist Nazl Tumori, Ctr Riferimento Oncol Aviano, Dept Pathol, Aviano, Italy
[2] Fdn IRCCS, Ist Nazl Tumori, Dept Diagnost Pathol & Lab Med, Milan, Italy
[3] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[4] IRCCS Humanitas Res Hosp, Dept Oncol & Hematol, Milan, Italy
[5] IRCCS, Ist Nazl Tumori, Ctr Riferimento Oncol Aviano, Via F Gallini 2, I-33081 Aviano, Italy
来源：
BLOOD | 2023年 / 141卷 / 18期
关键词：
REED-STERNBERG CELLS; PD-1; BLOCKADE; BRENTUXIMAB VEDOTIN; PHASE-II; T-CELLS; NIVOLUMAB; PEMBROLIZUMAB; RESISTANCE; SURVIVAL; TRANSPLANTATION;
D O I：
10.1182/blood.2022016590
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Classic Hodgkin lymphoma (cHL) is characterized by a tumor microenvironment (TME) containing inflammatory/ immune cells. Follicular lymphoma, mediastinal gray zone lymphoma, and diffuse large B-cell lymphomas may show a TME containing inflammatory/immune cells, but the TMEs are quite different. In B-cell lymphomas and cHL, programmed cell death 1 (PD-1)-PD ligand 1 pathway blockade drugs differ in their effectiveness among patients with refractory/relapsed disease. Further research should explore innovative assays that could reveal which molecules influence sensitivity or resistance to therapy in an individual patient.
引用
收藏
页码：2187 / 2193
页数：7
相关论文
共 50 条
  • [11] Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance
    Li, Yaqi
    Liu, Jing
    Gao, Long
    Liu, Yuan
    Meng, Fang
    Li, Xiaoan
    Qin, F. Xiao-Feng
    IMMUNOLOGY LETTERS, 2020, 220 : 88 - 96
  • [12] Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients
    Karihtala, Kristiina
    Leivonen, Suvi-Katri
    Karjalainen-Lindsberg, Marja-Liisa
    Chan, Fong Chun
    Steidl, Christian
    Pellinen, Teijo
    Leppa, Sirpa
    BLOOD ADVANCES, 2022, 6 (06) : 1919 - 1931
  • [13] Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy
    Heij, Lara
    Bednarsch, Jan
    Tan, Xiuxiang
    Rosin, Mika
    Appinger, Simone
    Reichel, Konrad
    Pecina, Dana
    Doukas, Michail
    van Dam, Ronald M.
    Vallejo, Juan Garcia
    Ulmer, Florian
    Lang, Sven
    Luedde, Tom
    Rocha, Flavio G.
    Sivakumar, Shivan
    Neumann, Ulf Peter
    CELLS, 2023, 12 (06)
  • [14] Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy
    Lu, Chia-Sing
    Lin, Ching-Wen
    Chang, Ya-Hsuan
    Chen, Hsuan-Yu
    Chung, Wei-Chia
    Lai, Wei-Yun
    Ho, Chao-Chi
    Wang, Tong-Hong
    Chen, Chi-Yuan
    Yeh, Chen-Lin
    Wu, Sean
    Wang, Shu-Ping
    Yang, Pan-Chyr
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [15] Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy
    Menzel, Johannes
    Black, Joshua C.
    CANCER DISCOVERY, 2020, 10 (02) : 179 - 181
  • [16] Checkpoint blockade therapy in Hodgkin lymphoma: improved response through combination with JAK inhibition
    Weniger, Marc A.
    Kueppers, Ralf
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [17] Update on checkpoint blockade therapy for lymphoma
    Kline, Justin
    Bishop, Michael R.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [18] Synchronizing the use of allogeneic hematopoietic cell transplantation in checkpoint blockade therapy for Hodgkin lymphoma
    Mussetti, Alberto
    Vilaseca, Anna Bosch
    Parody, Rocio
    Paviglianiti, Annalisa
    Domingo-Domenech, Eva
    Sureda, Ana Maria
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (09) : 809 - 818
  • [19] Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy
    Lee, Yu-Hung
    Yu, Ching-Fang
    Yang, Ying-Chieh
    Hong, Ji-Hong
    Chiang, Chi-Shiun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 14
  • [20] New key factors in the outcome of Hodgkin's lymphoma cases: Tumor microenvironment and mitotic checkpoint
    Garcia, JF
    Sanchez-Aguilera, A
    Montalbn, C
    Dominguez, P
    Sanchez-Verde, L
    Morente, MM
    Garcia-Cosio, M
    Bellas, C
    Romagosa, V
    Menarguez, J
    Mestre, MJ
    Fresno, MF
    Piris, MA
    MODERN PATHOLOGY, 2006, 19 : 226A - 226A
12345